Moderna forecasts weaker sales as COVID vaccine demand wanes - National
Moderna said on Thursday its 2023 sales would only hit the low end of its previous forecast, reflecting weaker demand for COVID-19 vaccines.
Source: globalnews.ca
Stay updated with breaking news from Michael Yee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Moderna said on Thursday its 2023 sales would only hit the low end of its previous forecast, reflecting weaker demand for COVID-19 vaccines.
Operator: Welcome to Amarin Corporation's conference call to discuss its third quarter 2023 financial results and business updates.
MRNA earnings call for the period ending September 30, 2023.
Around 20 million people need to be vaccinated with Moderna's updated COVID-19 vaccine for the company to reach US$2 billion in 2023 sales.
AMRN earnings call for the period ending September 30, 2023.